Livifem 2,5 mg TABLET
PDF Leaflet Revision Date: 05 May 2015
Clinical Summary
Quick overview from the medicine insert
Indication
Symptomatic treatment of menopausal symptoms and prevention of osteoporosis.
Dosage (summary)
1 tablet daily; start at least 12 months after last menstrual bleed for natural menopause.
Onset of Action / Duration
Onset: 30 mins, Duration: < 2 days
Special Populations
- Elderly
- Hepatic impairment
Pregnancy & Breastfeeding
Contraindicated in pregnancy and breastfeeding.
Key Drug Interactions
- Enzyme inducers may decrease efficacy
- Warfarin requires monitoring
Contraindications
- Pregnancy
- Lactation
- Hormone-dependent tumors
- VTE history
- Severe liver disease
Common side effects
- Vaginal bleeding
- Breast tenderness
- Weight increase
- Abnormal hair growth
Counselling Points
- Take at the same time daily
- Report any unusual bleeding
- Avoid if planning pregnancy
Serious warnings
- Increased risk of thromboembolic events
- Monitor for endometrial hyperplasia
Important Disclaimer
The Livifem 2,5 mg TABLET professional information leaflet below is the property of Organon South Africa and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
